Abstract 1061 Serum proteomics for the identification of biomarkers to flag predilection of COVID19 patients to various organ morbidities

Background: COVID19 pandemic has affected millions around the world. While many patients recovered completely with mild illness, many patients succumbed to various organ morbidities. Heterogeneity in clinical presentation of COVID19 infection has posed a challenge to clinicians around the world. It is therefore crucial to identify specific organ-related morbidity for effective treatment and better patient outcomes. Materials and Methods: COVID19 patients were screened and tested at various hospitals across New Delhi, India.